POLICY TOPIC
Prescription Drug Coverage
Resources, analysis, and news coverage on this issue, all in one place.
About This Issue
The Inflation Reduction Act (IRA) takes important steps to reduce drug prices and lower costs for people with Medicare and the program, such as capping beneficiary out-of-pocket spending; requiring Medicare to negotiate drug prices; and expanding eligibility for the full Part D low-income subsidy (LIS).
We support an implementation process that centers the beneficiary experience and look forward to building upon these landmark policies.
Resources, News & Coverage
100 items
- Medicare Watch Supreme Court Declines to Hear Medicare Drug Price Negotiation Challenge
- Medicare Watch New Study Underscores IRA’s Successes, Opportunities for Future Reforms
- Positions and Publications What the Inflation Reduction Act Means for Older Adults and People With Disabilities
- Medicare Watch IRA Leading to Better Medicare Coverage of Negotiated Drugs
- Medicare Watch Proposed Part D Payment Model Falls Short
- Comments Comments on Guarding U.S. Medicare Against Rising Drug Costs (GUARD) Model
- Medicare Watch Medicare Drug Price Negotiations: Selected Drugs for 2028
- Comments Comments on Proposed 2027 Medicare Advantage and Part D Policy Changes
- Medicare Answers Lowering Part D Costs: Federal, State, and Local Options
- Medicare Answers Understanding Medicare Part D and Prescription Drug Coverage
- Medicare Watch Reconciliation Bill More Harmful and Costly Than Previously Thought
- Yahoo Finance Medicare drug changes are coming next year. How to prepare. (opens in a new tab)
- Medicare Watch Negotiated Prices Take Effect for Ten Drugs in 2026
- Medicare Watch Part D Benefit Restructuring Reduces Out-Of-Pocket Exposure, Changes Risk to Prescription Coverage Access and Choice
- Medicare Watch New Research Confirms Importance of Drug Affordability and Low Out-of-Pocket Costs
- Medicare Watch Drug Pricing Executive Order Boosts Pharmaceutical Industry’s Goals
- Medicare Watch Proposed Rule Would Improve Medicare Advantage Prior Authorization and Transparency
- Comments Comments on Proposed 2026 Medicare Advantage Part D Policy Changes
- Medicare Watch Second Set of Part D Drugs for Medicare Negotiation Includes Blockbuster Diabetes and Weight-Loss Drugs
- Medicare Watch Millions of People With Medicare Drug Coverage to Save With New Cap in 2025
- Medicare Watch Medicare in 2025: Key Changes and Updates
- Medicare Watch Some People Losing “Deemed” Status for the Low-Income Subsidy Remain Eligible for Assistance
- Medicare Watch Millions See Cost Savings Under the Inflation Reduction Act
- Medicare Watch Comparing Plans is Especially Important This Open Enrollment Season Due to Changes in Part D Protections and New Options
- Medicare Watch Changes in Drug Coverage Coming in 2025 Could Influence Your Choice of Plan
- Medicare Watch Medicare Rights Supports Building on the IRA’s Cost Protections for People With Medicare and Other Coverage
- Press Release Medicare Rights Supports Legislation Extending Inflation Reduction Act Affordability Reforms to the Commercial Market
- Press Release Medicare Rights Center Celebrates the Anniversary of the Inflation Reduction Act and Applauds Monumental Prescription Drug Savings
- Medicare Watch Biden-Harris Administration Announces Billions in Savings from Drug Price Negotiations
- Medicare Watch On the Anniversary of the Inflation Reduction Act: Significant Part D Changes Already in Action, More to Come
- Medicare Watch Medicare Poised to Add Important HIV Drug to Preventive Service List
- Medicare Watch New Program to Help Willing Part D Plans Keep Premiums in Check
- Medicare Watch Guidance on Inflation Reduction Act’s Medicare Prescription Payment Plan Released
- KFF Health News Lack of Affordability Tops Older Americans’ List of Health Care Worries (opens in a new tab)
- Positions and Publications Medicare Reforms in the Inflation Reduction Act
- Medicare Watch Final Rules on Medicare Advantage Prior Authorization Offer Improvements, but More Change is Needed
- Medicare Watch Medicare Vaccine Uptake Increasing, Inflation Reduction Act’s Role Still Unknown to Many
- Medicare Watch New Data on Impact of Inflation Reduction Act Shows Lower Health Care Costs for Women
- Medicare Watch Study Shows Part D Plans Ratcheting Up Restrictions on Coverage
- Medicare Watch Changes to Part D: Lower Out-Of-Pocket Drug Costs in 2024 and 2025; Simplifications in 2025
- Medicare Watch Issue Brief Outlines Expected Drug Savings for Millions Under the Inflation Reduction Act
- Medicare Watch Medicare Drug Negotiations Officially Underway
- The New York Times If You’re on Medicare, You Could Save Money on Drugs This Year (opens in a new tab)
- Medicare Watch People Can Get Even More Extra Help in 2024
- Comments Comments on Proposed Changes to Medicare Advantage and Part D for 2025
- Medicare Watch Few Beneficiaries Know Part D Out-of-Pocket Cap Now in Effect
- Medicare Watch Administration Provides More Data on First 10 Drugs Subject to Price Negotiation
- Medicare Watch Medicare Rights Joins Legal Fight in Defense of Drug Price Negotiation
- Report Medicare Prescription Payment Plan (MPPP) Draft Guidance
- Medicare Watch Government Watchdog Urges Caution and Monitoring of Part D Rebate Programs
- Medicare Watch Part D Drug Negotiations Move Forward
- Medicare Watch Part D and Medicare Advantage Plans Stable for 2024
- Medicare Watch CMS Announces First 10 Drugs Subject to Price Negotiation
- Reuters Column: US Medicare drug negotiations a good start on bringing down healthcare costs (opens in a new tab)
- Press Release Centers for Medicare & Medicaid Services Announces First 10 Medicare Part D Drugs Subject to Negotiation Under the Inflation Reduction Act (IRA)
- Medicare Watch Inflation Reduction Act and Affordable Care Act Working Together to Lower Health Care Costs
- Medicare Watch Rising Drug Prices Demonstrate Need for Inflation Reduction Act’s Changes
- Medicare Watch Public Supports More Drug Price Regulation, Unaware of Inflation Reduction Act Provisions
- Medicare Watch HHS Projects Significant Medicare Beneficiary Savings Under the IRA
- Medicare Watch New Tools to Improve Access to Medicare Part D Financial Assistance
- Medicare Watch Merck Sues in Longshot Bid to Derail Medicare Drug Price Negotiation
- Medicare Watch Study Finds Older Adults Skipping Medications Due to Cost
- Medicare Watch Final Rule Makes Important Changes to Medicare Advantage and Part D
- Comments The Medicare Drug Price Negotiation Program
- Medicare Watch People with Medicare Could Soon See More Inflation Reduction Act Drug Pricing Relief
- Comments Part D Medicare Prescription Drug Inflation Rebate Program
- Comments Part B Medicare Prescription Drug Inflation Rebate Program
- Medicare Watch President’s Budget Outlines Policy and Spending Priorities
- Positions and Publications Improving the Effectiveness of Extra Help for Prescription Drugs
- Positions and Publications Improving Access to Extra Help for Prescription Drugs
- Medicare Watch Year-End Funding Package Includes Medicare and Medicaid Policies
- Medicare Watch New Enrollment Periods and Cost Savings Take Effect in 2023
- Medicare Watch Looking Ahead: Medicare in 2023 and Beyond
- Medicare Watch HHS Analysis Shows Higher Drug Prices Outpacing Inflation
- Press Release Medicare Rights Urges Swift Passage of the Inflation Reduction Act of 2022
- Medicare Watch As Congress Looks to Address Medicare Prescription Drug Affordability, Now Is the Time to Make Your Voice Heard
- Medicare Watch Senate Democrats Release Updated Prescription Drug Pricing Bill
- Medicare Watch Medicare Rights Trends Report Shows Part D Enrollees Continue to Struggle with Costs and Other Barriers to Care
- Medicare Watch New Campaign Urges Senate Action on Prescription Drug Pricing
- Medicare Watch Drug Prices Remain High and Unpredictable as Beneficiaries Look to Lawmakers for a Fix
- Medicare Watch Further Evaluation of Potential Caps in Part D Shows Promise for Beneficiary Impact
- Medicare Watch New KFF Report Examines Beneficiary Exposure to Part B Drug Costs
- Medicare Watch Drug Prices Already Rising in 2022
- Medicare Watch Medicare Rights Supports Important Proposals for Medicare Advantage and Part D Plans
- Medicare Watch Medicare Rights Joins 90 Organizations Urging Senate to Pass Drug Pricing Reforms
- Letters Letter to Senators Urging Drug Pricing Reform
- Medicare Watch Proposed Rule Might Reduce Out-of-Pocket Drug Costs for Some People with Medicare
- Medicare Watch “Build Back Better” Bill Would Help Millions of People with Medicare Afford Medications
- Medicare Watch Medicare Rights Applauds Passage of the House Build Back Better Bill
- Medicare Watch Analysis Shows Benefits for People with Medicare in the Current “Build Back Better” Bill
- Medicare Watch Prescription Drug Cost Reform is a Welcome Addition to the “Build Back Better” Budget Bill
- Medicare Watch Now Is the Time to Weigh-in on the “Build Back Better” Budget Bill
- Medicare Watch Tell Your Members of Congress to Advance Critical Medicare and Medicaid Reforms
- Medicare Watch New Poll Shows Considerable Public Support for Proposed Medicare Changes in the Build Back Better Plan
- Inside Medicare Rights Medicare Rights Advocates for Key Health Care Reforms in Congressional Budget Bill
- Medicare Watch “Build Back Better” Key Health Provisions Begin to Take Shape
- Medicare Watch As Congress Weighs Legislation, New Report Examines How Caps on Part D Spending Would Affect People with Medicare
- Medicare Watch Budget Resolution Process Provides Historic Opportunity to Improve Medicare and Medicaid
- Medicare Watch Biden Administration Calls on Congress to Address High Prescription Drug Prices
- Medicare Watch Senate Lays Groundwork for Legislation That Includes Major Health Care Improvements
No items match these filters.
Become a Medicare Champion
Champions keep the helpline free, the policy work loud, and the next generation of Medicare strong. When someone calls us at their most confused and frightened, a Champion is the reason we can pick up. Will you be one?
Yes, I'll Be a Champion →